The TASS media network reported today the recombinant human adenoviral-based, two-part Sputnik M Vaccine for adolescents had been approved for use in Russia.
The Deputy Director-General of the Gamaleya Research Institute of Epidemiology and Microbiology Denis Logunov stated at a press conference on November 24, 2021, "The use of the Sputnik M vaccine by people twelve to 17 years was authorized today.’
Russia Launches Sputnik M Vaccine for AdolescentsÂ
Caregivers of Childhood Cancer Survivors Concerned About COVID-19 Vaccines
Concerns, expressed early in the rollout, included lack of safety and efficacy data, particularly in children with cancer
RSNA: CT Imaging for Cancer Down During COVID-19 Peak in 2020
In post-COVID-19 peak period in 2020, CT volume still down for cancer screening and initial workup with inconsistent recovery for active cancer
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 22 to 24, 2021. This …
Enterovirus D68 Detections Lower Than Expected in 2020
382 EV-D68 detections in respiratory specimens from patients <18 in 2018, number dropped to six in 2019, 30 in 2020
Pandemic Had Greater Effect on Work-Life Balance for Female Physicians
A sizable gender gap evident for risk of depression and anxiety